# K082070: Nuvasive Lateral Plate System

- Pathway: 510(k) (Special)
- Applicant: Nuvasive, Inc.
- Decided: Sep 24, 2008 after 64 days
- Product code: KWQ (Appliance, Fixation, Spinal Intervertebral Body)
- Device class: 2
- Regulation: 21 CFR 888.3060
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
76 later devices descend from it; 3 cite it directly.
0 of 77 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K091071: Nuvasive Lateral Plate System (2009), 74 descendants of its own
- K142699: LITe Plate System (2014), 46 descendants of its own
- K120092: Plymouth Thoracolumbar Plate System (2012), 41 descendants of its own
- K150449: LITe Plate System (2015), 24 descendants of its own
- K133194: Diamond Rattlesnake System (2014), 17 descendants of its own

## Indications for use
The NuVasive Lateral Plate System is indicated for use as an adjunct to fusion via a lateral or anterolateral surgical approach above the bifurcation of the great vessels in the treatment of thoracic and thoracolumbar (T1-L5) spine instability or via the anterior surgical approach, below the bifurcation of the great vessels in the treatment of lumbar and lumbosacral (LI-SI) spine instability as a result of fracture (including dislocation and subluxation), tumor, degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), scoliosis, kyphosis, lordosis, spinal stenosis, or a failed previous spine surgery.

Source page: https://510kreport.com/device/K082070
Methodology: https://510kreport.com/methodology